British pharmaceutical giant GSK announced that its current CEO, Emma Walmsley, will step down after nearly nine years in the role. She will be succeeded by...
GSK (NYSE: GSK) is actively negotiating with the U.S. government to explore options for reducing drug prices. This initiative comes as part of a broader response...